| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)
|
Hamaguchi, Tetsuya
|
|
2011
|
14 |
3 |
p. 226-233
|
artikel
|
| 2 |
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum
|
Schoennemann, Katrine R.
|
|
2011
|
14 |
3 |
p. 219-225
|
artikel
|
| 3 |
Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden
|
Mousavi, Seyed Mohsen
|
|
2011
|
14 |
3 |
p. 285-289
|
artikel
|
| 4 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy
|
Saito, Masaaki
|
|
2011
|
14 |
3 |
p. 295-299
|
artikel
|
| 5 |
Erratum to: p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population
|
Song, Hye-Rim
|
|
2011
|
14 |
3 |
p. 248
|
artikel
|
| 6 |
Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer
|
Nomura, Eiji
|
|
2011
|
14 |
3 |
p. 279-284
|
artikel
|
| 7 |
Gastric adenocarcinoma with rhabdoid morphology
|
Shomori, Kohei
|
|
2011
|
14 |
3 |
p. 290-294
|
artikel
|
| 8 |
IL-6 serum levels predict postoperative morbidity in gastric cancer patients
|
Szczepanik, Antoni M.
|
|
2011
|
14 |
3 |
p. 266-273
|
artikel
|
| 9 |
Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study
|
Huang, Shiang-Fen
|
|
2011
|
14 |
3 |
p. 257-265
|
artikel
|
| 10 |
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1
|
Aoyama, Toru
|
|
2011
|
14 |
3 |
p. 274-278
|
artikel
|
| 11 |
Negative trial results are important to understand the mechanisms of multimodality therapy in gastric cancer
|
Schuhmacher, Christoph
|
|
2011
|
14 |
3 |
p. 203-205
|
artikel
|
| 12 |
p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population
|
Song, Hye-Rim
|
|
2011
|
14 |
3 |
p. 242-247
|
artikel
|
| 13 |
Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer
|
Shim, Hyun Jeong
|
|
2011
|
14 |
3 |
p. 249-256
|
artikel
|
| 14 |
Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany
|
Jaworski, Radoslaw
|
|
2011
|
14 |
3 |
p. 234-241
|
artikel
|
| 15 |
Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2
|
Miyashiro, Isao
|
|
2011
|
14 |
3 |
p. 212-218
|
artikel
|
| 16 |
Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials
|
Takiuchi, Hiroya
|
|
2011
|
14 |
3 |
p. 206-211
|
artikel
|
Tijdschrift beschrijving